Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours.

Bladder cancer Non–muscle invasive Outcome Quality Surgical technique Transurethral resection of bladder tumour

Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
02 2021
Historique:
received: 01 05 2020
revised: 17 06 2020
accepted: 28 06 2020
pubmed: 21 7 2020
medline: 20 11 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

Transurethral resection of bladder tumour (TURBT) for bladder cancer (BC) is an underappreciated common urological procedure. TURBT outcomes are highly variable, and results are dependent on judgement and surgical skill. To perform a narrative review and identify optimal best practice in TURBT including preparation, choice of equipment, procedural steps, surgical technique, and management of difficult scenarios and complications. Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched. Important studies were identified and reviewed by an international panel of urologists representing major urological societies and guideline panels with a record of academic publication in this field. In areas where the group identified a lack of evidence or agreement, discussions took place until a consensus was reached. A total of 814 studies were identified and 43 were included. The majority were retrospective (level of evidence 3), with only two prospective randomised trials. Four broad themes were identified, which formed the basis for the review: (1) the role of TURBT within the overall management of BC, (2) TURBT techniques, (3) measurement of outcomes including quality control and checklists, and (4) postoperative management. Familiarity with all aspects of the procedure is necessary to minimise morbidity and improve oncological outcomes. Development of new instruments and techniques, and prospective audit of TURBT outcomes are important future goals. TURBT is a common and challenging operation with known variable outcomes. To reduce these variations and optimise outcomes, best practice based on evidence and expert opinion is recommended. Transurethral resection of bladder tumour (TURBT) is a common but deceptively difficult urological operation. Optimal outcomes depend on experience and surgical skill. An international group of experienced TURBT surgeons review critical aspects of the procedure and share best practice to stimulate further discussion.

Identifiants

pubmed: 32684515
pii: S2588-9311(20)30088-2
doi: 10.1016/j.euo.2020.06.010
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-19

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Hugh Mostafid (H)

Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK. Electronic address: Hugh.Mostafid@nhs.net.

Ashish M Kamat (AM)

Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.

Siamak Daneshmand (S)

Department of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Joan Palou (J)

Department of Urology, Fundacio Puigvert, Universidad Autonoma de Barcelona, Barcelona, Spain.

John A Taylor (JA)

Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.

James McKiernan (J)

Department of Urology, New York Presbyterian Hospital/Columbia University Medical Center, New York City, NY, USA.

James Catto (J)

Academic Urology Unit, University of Sheffield, Sheffield, UK.

Marko Babjuk (M)

Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Mark Soloway (M)

Division of Urology, Memorial Hospital, Hollywood, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH